Utah Medical Products, Inc.
UTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $10 | $10 | $10 | $9 |
| % Growth | -1.4% | 2.5% | 6% | – |
| Cost of Goods Sold | $5 | $5 | $4 | $4 |
| Gross Profit | $5 | $5 | $6 | $5 |
| % Margin | 51.6% | 50.8% | 57% | 58.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $6 |
| SG&A Expenses | $2 | $2 | $1 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $2 |
| Other Operating Expenses | $0 | $0 | $1 | -$5 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $3 | $3 | $3 | $3 |
| % Margin | 26.6% | 32.1% | 32.5% | 32% |
| Other Income/Exp. Net | $1 | $1 | $1 | $1 |
| Pre-Tax Income | $3 | $4 | $4 | $4 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $3 | $3 | $3 | $3 |
| % Margin | 26.8% | 30.6% | 31.3% | 31.7% |
| EPS | 0.79 | 0.92 | 0.92 | 0.86 |
| % Growth | -14.1% | 0% | 7% | – |
| EPS Diluted | 0.82 | 0.94 | 0.92 | 0.86 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $4 | $5 | $4 | $4 |
| % Margin | 41.4% | 46% | 43.1% | 43.5% |